Project title: Intra-arterial Peptide Receptor Radionuclide Therapy (IA-PRRT) using 90Y-DOTA-TOC

Thomas Hope, MD University of California, San Francisco

Thomas Hope, MD
  • Status: Active
  • Year(s): 2016
  • Grant Type: Collaborative
  • Research Type: Clinical
  • Primary Site: Other
  • Area of Inquiry: Clinical trials
The primary goals are to evaluate possible liver, bone marrow and kidney toxicity after hepatic arterial injection and evaluate imaging tumor response to 90Y-DOTA-TOC hepatic arterial injection three months after treatment. Dr. Hope will evaluate possible 90Y-DOTA-TOC hepatic, marrow and renal toxicity and imaging of tumor response to hepatic arterial injection, three months post-therapy.

Additional Details

  • City: San Francisco
  • Grant Partner: Education and Research Foundation for Nuclear Medicine and Molecular Imaging
  • Sponsor: Margie & Robert E. Petersen Foundation
« Back to all funded research projects